Segra International Completes First Export of Cannabis Plantlets from Canada to the USA

CANADA: Segra International Corp, a leading cannabis agriculture technology company, is pleased to announce its first successful export of Verified Segra Stock™ Cannabis plantlets to the Biopharmaceutical Research Company (BRC), one of the first groups in the USA to receive approval from the DEA to cultivate Cannabis for scientific research purposes.

This shipment marks a tremendous milestone in the evolution of the US cannabis industry, as it represents one of the first imports of live Cannabis plants to a federally licensed US cultivator. In recent months, the DEA has issued a select number of licenses to several groups in the US to allow for the cultivation of Cannabis for scientific research purposes. BRC, based in California, is among the first companies granted a license and is now operational. Segra’s Verified Segra Stock™ plantlets will provide BRC with standardized and validated starting materials produced through plant tissue culture, and backed by extensive agronomic data and Cannabis plant pathogen screening.

BRC works with research groups studying Cannabis and Cannabis flower to understand the plant in a scientific and federally regulated environment. Under the federal licensing regime, BRC is only allowed to source genetics and starting material from DEA-compliant or federally legal sources.

“Segra’s Verified Segra Stock™ guarantee means our plantlets are DNA fingerprinted and pathogen-free with virtually no risk of pathogen introduction to the receiving grow facility.

Starting with this input material is critical to effectively grow replicable crops, something highly valued by researchers who are studying the finished product of the Cannabis plant and its derivatives,” said Jamie Blundell, CEO of Segra International. “Furthermore, Segra’s VNTR DNA Fingerprinting technology allows BRC to order plantlets and cultivars with certainty, knowing they are receiving the same input material with each shipment. The application of VNTR DNA fingerprinting technology can be used throughout the supply chain for track and trace purposes, from plantlet to flower, translating this certainty to researchers who can study the same product repeatedly.”

“At BRC, we are focused on developing federally compliant active pharmaceutical ingredients for federally compliant researchers examining the therapeutic effects of cannabis,” said George Hodgin, CEO of Biopharmaceutical Research Company. “We’re fortunate to be working with Segra to offer our clients a wide range of clean, high-quality Cannabis of specific chemical expressions and flower types to help them better understand the applications of the Cannabis plant.”

Learn more about Segra’s services and premium cultivars by viewing the 2021 Cultivar and Services Catalogue.

 

 

The First Cannabis IP-Licensing Company, Breeder’s Best, Officially Launches

New company brings together cannabis industry leaders including attorney-scientist Dale Hunt, researcher-physician Ethan Russo, and botanist-author Robert C. Clarke

CALIFORNIA: Cannabis industry pioneers, Dale Hunt, PhD, JD, Ethan Russo, MD, and Robert C. Clarke have joined forces to create Breeder’s Best, the first cannabis company to focus on intellectual property (IP) protection for independent plant breeders and licensing IP for access to markets worldwide. Breeder’s Best brings a global plant-licensing model, proven successful in other agriculture industries, to cannabis.

The liberalization of global cannabis laws and growing public acceptance of cannabis have created a rapidly escalating demand for cannabis flower, as well as therapeutics and products made with cannabis. According to a report by Prohibition Partners, the international cannabis industry is projected to grow to more than $103.6 billion by 2024.

While the cannabis industry presents significant opportunity, there exists a critical disconnect that separates the creativity of breeders from the markets that are demanding products with unique and proven genetic profiles. Additionally, there is typically very little IP protection to support good partnerships between breeders and cannabis brands. Breeder’s Best will connect these two key stakeholders while legally protecting the genetic inventiveness of breeders.

Breeder’s Best founder and CEO Dale Hunt says, “Our mission is to connect the best Cannabis genetics to the greatest needs and most promising commercial opportunities. To do that, we have assembled an unparalleled team of experts with deep experience at every level of the cannabis supply chain. As the industry matures, Breeder’s Best will be positioned to meet the demands of the increasingly professional and GMP-oriented marketplace while doing business in a way that benefits breeders and directs profitable and reliable business to growers who may otherwise be left behind. With our vision, team, model, know-how, and relationships, Breeder’s Best is poised to become the global leader in patented cannabis genetics and related products.” Dr. Hunt has been practicing IP law for 23 years. He has a PhD in plant cellular and molecular biology and has obtained thousands of patents and plant variety rights for his clients in more than 30 countries.

“Cannabis use is finally normalizing. At Breeder’s Best, we present independent Cannabis breeders the opportunity to protect their unique varieties and assist them in placing those genetics in lucrative markets. This is a great service to breeders who would prefer to focus on the art and science of breeding, instead of dealing with the mechanics of commercialization,” said Breeder’s Best Director of Agronomy and Genetics, Robert C. Clarke. Mr. Clarke is a 40-year cannabis industry veteran, revered for his books Marijuana Botany, published in 1982, and Cannabis: Evolution and Ethnobotany, published in 2013.

The Cannabis plant produces over 450 chemical components, many of which are potentially therapeutic. However, decades of cannabis prohibition have resulted in a lack of genetic diversity worldwide and a predominance of only a small fraction of potential agents.

“We have just begun to scratch the surface of everything that cannabis can do to improve and enhance our lives,” said Dr. Ethan Russo. “That’s what Breeder’s Best will do. Identifying, selectively breeding for and utilizing specific chemical components will truly transform medicine in the coming decades.” Dr. Russo is a board-certified neurologist, preeminent medical cannabis expert, author of more than 50 peer-reviewed medical journal articles and a veteran of GW Pharmaceuticals where he served as Senior Medical Advisor as well as the Sativex® and Epidiolex® clinical trial Study Physician and Medical Monitor.


About Breeder’s Best:  Breeder’s Best is a privately held Cannabis IP genetics company organized as a B Corporation to demonstrate our commitment to independent Cannabis breeders and to meeting the worldwide needs of patients and consumers for superior products. To learn more about Breeder’s Best visit www.breedersbest.com.

Oregon State University’s Global Hemp Innovation Center Receives $1M For Genetics Research

OREGON: Oregon State University’s Global Hemp Innovation Center has received a $1 million gift to explore hemp genomics, research that can grow understanding of how hemp may be used in health and nutrition products, textiles and construction materials.

The gift to the OSU Foundation was provided by Oregon CBD, a hemp seed research and development company.

The Global Hemp Innovation Center was launched in June by OSU’s College of Agricultural Sciences and is the largest, most comprehensive hemp research center in the nation. Led by Jay Noller, the center is based in the College of Agricultural Sciences, with faculty from multiple disciplines and colleges across OSU, and has a global reach that includes partnerships in four countries.

“We have been overwhelmed by the outpouring of support and interest in our work,” said Jay Noller, an OSU professor and internationally recognized hemp expert.

Noller said that while some private sector genomic studies of hemp have taken place, very little information is available publicly for research.

“There is a tremendous amount of possibility with hemp, and understanding the genetics is key,” said Seth Crawford, who with his brother Eric, co-own and manage Oregon CBD. “Philosophically, we believe the public land grant university needs to be the epicenter of that research so that all can benefit from the findings.

“We believe OSU is the right place to lead this research,” Crawford said.

Oregon CBD is a family-owned business with longtime ties to OSU that go back several generations. Seth and Eric Crawford both have several degrees from the university and prior to starting the family business Seth taught in the School of Public Policy for 13 years and contributed in 2015 to some of the Oregon Health Authority’s early cannabis policies.

“This also provides us the added satisfaction of giving back to the university that has been a part of our family since my grandfather Loren Gardner graduated in 1954,” Seth Crawford said.

The gift is the first major private donation the center has received since its launch, and is unique in that it allows scientists to publicly share data and collaborate with others engaged in the study of hemp.

“This investment accelerates our leadership and establishes OSU at the forefront in genomic research in hemp,” said Alan Sams, dean of the College of Agricultural Sciences.

Noller said genomic research tools will allow better understanding of the DNA present within different hemp varieties. He said this information will provide insights for developing specific hemp varieties for uses ranging from health and nutrition products, to the manufacture of textiles, and use in construction materials. The research also may lead to stronger, more disease resistant, higher yielding plants, and provide understanding of the genes that influence the production of chemical compounds in the plant. With this knowledge, Noller said growers might be able to better predict the levels of hemp essential oil components that are synthesized in different plant varieties.

Kelly Vining, an assistant professor and researcher in OSU’s Department of Horticulture, will lead the university’s hemp genomic research.

“Looking at the most intimate secrets of life in plants is powerful,” Vining said. “With hemp, the prospects are additionally exciting because it not only holds such interesting promise, but it is just a gnarly plant genome – the bioinformatics are challenging. We are now able to explore that promise and challenge, while also being among the first to share our findings with the world.”

New DNA Test Determines Cannabis Compatibility

Endocanna Health Creates New Paradigm of Personalized Medicine Connecting Human DNA with Cannabis Genetic Profiles

CALIFORNIA: Endocanna Health this week launches its Cannabinoid DNA Variant Test”  — billed as the most comprehensive personalized cannabis DNA test available on the market today. Developed by a team of renowned scientists at Endocanna Heath, a biotechnology research company, this direct-to-consumer DNA test kit, analyzes an individual’s DNA markers and provides science backed recommendations based on their specific DNA in a way no other test has been able to do before.

Until now, there was no comprehensive way to test one’s unique DNA and align it with the latest research to predict how humans may respond to cannabis. For example, some individuals with a specific variant in the gene CYP2C9 may not metabolize THC well and should be cautious about consuming edible products. The test also screens for genetic variants linked to the tendency to experience greater levels of anxiety, drug dependence, and a host of other traits. Therefore, this test allows people to have positive outcomes, helps individuals demystify their cannabis experiences, and further establishes cannabis as a viable solution to alleviate health and wellness issues.

Endocanna HealthEndocanna Health utilizes a patent pending algorithm and process to develop its Cannabinoid DNA Variant Report™. DNA for the test is obtained through either a simple saliva swab or existing genetic data from popular DNA testing services like Ancestry, 23andMe, Family Tree DNA or MyHeritageDNA. Consumers can then use their personalized reports to discover the right products for their specific genetics with product suggestions from Endocanna Heath, providing a full spectrum experience.

“Our goal in establishing Endocanna Health is simple,” says Len May, Endocanna Health co-founder and CEO, “to provide individuals with the tools and confidence to incorporate cannabis into their lives using the most up-to-date research available today. Information that is accurate, but most importantly personal and unique to an individual’s DNA. The goal of our reports is to help people identify which products may help them, and try to give them the best possible outcomes with cannabis. We are gratified to help the millions of people who use cannabis or who may want to begin using cannabis make the most informed decisions when it comes to using the plant.”